Market Overview

Morning Market Movers

Share:
Related ALNY
5 Biotech Stocks On Deck With The FDA
What's The Street Think Of Alnylam Pharmaceuticals New Drug Data?
Benitec And Bluebird Bio, Gene Therapy Coming Of Age? (Seeking Alpha)
Related MRK
9 Top Sell Ideas From Oppenheimer's Technical Analysis Division
Merck Announces Phase 3 Study of Single-Dose EMEND® (fosaprepitant dimeglumine) for Injection Regimen Met Primary Endpoint
Allergan nabs rights to Merck's CGRP receptor agonists for migraines for $250M (Seeking Alpha)

Alnylam Pharmaceuticals (NASDAQ: ALNY) rose 34.16% to $88.83 after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck (NYSE: MRK). Genzyme and Alnylam expanded their collaboration on rare genetic diseases.

Rexahn Pharmaceuticals (NYSE: RNN) jumped 33.77% to $1.53. Rexahn Pharmaceuticals shares have jumped 235.29% over the past 52 weeks, while the S&P 500 index has gained 25.27% in the same period.

Rosetta Genomics (NASDAQ: ROSG) moved up 33.23% to $4.25 after the company reported that it has signed a master service provider agreement with a major global biopharmaceutical company.

Teche Holding Company (NYSE: TSH) shares jumped 28.44% to $70.00 after IBERIABANK (NASDAQ: IBKC) announced an agreement to acquire Teche Holding.

Posted-In: market moversNews Intraday Update Markets Movers

 

Related Articles (ALNY + IBKC)

Around the Web, We're Loving...

Get Benzinga's Newsletters